Ligand, CURx Pharmaceuticals deal

Ligand expanded an August 2013 deal with CURx to include the development and commercialization of Ligand's Captisol-enabled lamotrigine

Read the full 181 word article

How to gain access

Continue reading with a
two-week free trial.